Showing 31-40 of 48 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Optimized bone marrow conditioning and tolerance assays to advance cell-based therapies for diabetes | Stanford University | Stephan Ramos | Cures | 01-March-2026 to 28-February-2029 | $285,000.00 |
| Endothelial cells for islet replacement in diabetes | Stanford University | Martin Neukam | Cures | 01-April-2024 to 31-March-2027 | $251,600.00 |
| Development of an injectable immunomodulatory niche technology for induction of immune tolerance to islet cell transplants | Stanford University | Eric Appel | Cures | 01-January-2025 to 31-December-2026 | $600,000.00 |
| Ultrafast Insulin-Pramlintide Co-formulations | Stanford University | Eric Appel | Improving Lives | 01-September-2022 to 31-December-2026 | $795,000.00 |
| Development of Uni-molecular Glucose-responsive Insulin | Stanford University | Danny Hung-Chieh Chou | Improving Lives | 01-April-2022 to 31-March-2026 | $749,998.34 |
| Building the Evidence to Address Disparities in Young children with Type 1 Diabetes: BEADY-T1D | Stanford University | Ananta Addala | Improving Lives | 01-February-2025 to 31-January-2029 | $943,983.20 |
| Real time monitoring of a cell therapy product to assess and modify transplant health post-engraftment in patients with type 1 diabetes | Minutia | Katy Digovich | Cures | 01-November-2022 to 31-March-2026 | $1,198,600.00 |
| Transcriptional memory in human islet organogenesis | Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) | Eiji Yoshihara | Cures | 01-April-2022 to 31-March-2027 | $749,995.50 |
| Broad Scope CMC, Non-Clinical, and Regulatory Support | Dark Horse Consulting | Nathan Manley | Cures | 01-September-2025 to 31-December-2026 | $85,000.00 |
| Brown University IND Readiness Gap Analysis | Dark Horse Consulting | Nathan Manley | Cures | 01-June-2025 to 31-December-2025 | $87,770.00 |